Matspin Tablet
Marketer
Matias Healthcare Pvt Ltd
Salt Composition
Cinnarizine (20mg) + Dimenhydrinate (40mg)
Overview Matspin Tablet
Vertigo is effectively managed with Vertigen, a combined-action tablet. Its mechanism involves relaxing the ear's blood vessel muscles, thereby enhancing blood flow. Simultaneously, it neutralizes a neurotransmitter linked to vertigo's dizziness. For optimal absorption and to prevent gastric distress, Vertigen should be taken with meals, consistently at the same time each day as prescribed. Missed doses should be taken immediately upon recollection; complete the prescribed course and avoid abrupt cessation without consulting your physician. Dry mouth and abdominal discomfort are potential side effects; increased water intake, hard candies, and diligent oral hygiene can mitigate dryness. Drowsiness and dizziness are also possible; refrain from driving or demanding tasks until the drug's effects are known. Alcohol consumption is generally discouraged during treatment. Prior to commencing Vertigen, disclose any history of peptic ulcers, asthma, or hypotension. Inform your doctor about all other medications to prevent potential interactions. Pregnant or lactating individuals should seek medical guidance before using this medication.
Uses of Matspin Tablet
Managing Dizziness
Major Benefits of Matspin Tablet:
Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Matspin Tablet with a meal.
Common Side effects of Matspin Tablet:
- Drowsiness
- Headache
- Stomach pain
- Dryness in mouth
How to use Matspin Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Matspin Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Matspin Tablet works:
Matspin Tablet unites Cinnarizine and Dimenhydrinate, two distinct medications. Cinnarizine, a calcium channel blocker, mitigates inner ear blood vessel constriction, thereby enhancing blood flow in the ear. Dimenhydrinate, an antihistamine, counteracts histamine, a neurotransmitter contributing to the dizziness associated with vertigo.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Matspin Tablet and alcohol may result in significant sedation.
PregnancyCONSULT YOUR DOCTOR
Use of Matspin Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the benefits against potential risks prior to prescription. Consult your doctor for advice.
Breast feedingCONSULT YOUR DOCTOR
Data on Matspin Tablet use while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Taking Matspin Tablets may cause drowsiness, blurred vision, and dizziness, reducing alertness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Matspin Tablet's use in individuals with renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Matspin Tablet's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Matspin Tablet :
Should you forget a Matspin Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Matspin Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |


